LANXESS completes acquisition of Brazilian biocide manufacturer IPEL

Cologne
Specialty chemicals company LANXESS today, February 3, 2020, completed the acquisition of Itibanyl Produtos Especiais Ltda. (IPEL). The competent anti-trust authorities approved the transaction beginning of January.

IPEL with headquarters in Jarinu, São Paulo, is one of Brazil’s leading biocide manufacturers and generated sales in the lower double-digit million euro range in 2018. With the acquisition, LANXESS is strengthening its position as one of the world’s leading manufacturers of antimicrobial active ingredients and formulations. In addition to around 100 employees and the production facility, LANXESS has taken over the Brazilian company’s laboratory facilities.

IPEL generates the majority of its sales with biocides and specialty chemicals for the paint and coating industry. The product portfolio also includes preservatives and fungicides for process control in water treatment as well as active ingredients for disinfection and cleaning agents.

MORE ABOUT THIS TOPIC

PRESS RELEASE
LANXESS subsidiary Saltigo produces among others active ingredients for the pharmaceutical and agro industry.

LANXESS at Chemspec Europe 2025

May 28, 2025
PRESS RELEASE
Reactor in ZeTO

Catalysis for success – efficient, selective, flexible

May 27, 2025
PRESS RELEASE
Since August 1, 2013, specialty chemicals Group LANXESS is steering its global business from the LANXESS Tower in Cologne.

LANXESS starts fiscal year 2025 with significant earnings increase

May 09, 2025
PRESS RELEASE
Glass bottles with fragrances

LANXESS to showcase aroma chemicals at SIMPPAR 2025

May 06, 2025
PRESS RELEASE
LANXESS corporate headquarters in Cologne

Top ratings for LANXESS: CDP recognizes commitment to climate and water protection

April 22, 2025